Bidness Etc |
Boehringer, Eli Lilly's Jardiance gets FDA approval for diabetes treatment
Pharmaceutical Business Review The US Food and Drug Administration (FDA) has granted approval for Boehringer Ingelheim Pharmaceuticals (BIPI) and Eli Lilly and Company's Jardiance (empagliflozin) tablets as an addition to diet and exercise to improve glycemic control, or blood … FDA approves Jardiance to treat type 2 diabetesFDA.gov Lilly Diabetes Drug Secures FDA ApprovalInside Indiana Business (press release) Jardiance Approved by FDA for Type 2 Diabetes TreatmentHCPLive The Republic –dailyRx all 61 news articles » |
More details can be found at www.diabeteshowto.com
Discussion
Comments are disallowed for this post.
Comments are closed.